Efficacy and tolerability of add-on Lacosamide treatment in adults with Lennox-Gastaut syndrome: An observational study.

Purpose: To evaluate the efficacy, safety, and tolerability of lacosamide in adults with LGS in the clinical setting.

Method: The present report is a retrospective, open-label treatment study carried out from June 2013 to December 2014 at the National Institute of Colombia. Lacosamide was introduced as add-on therapy.

Mortality in patients with refractory temporal lobe epilepsy at a tertiary center in Cuba.

Objectives: We aimed to investigate the prevalence and risk of mortality in patients with refractory temporal lobe epilepsy.

Methods: Eligible patients included all adults referred to the National Institute of Neurology (NIN) in Havana, Cuba. All patients were followed up for 9 years.